Financhill
Sell
26

AFIB Quote, Financials, Valuation and Earnings

Last price:
$0.0000
Seasonality move :
-25.56%
Day range:
$0.0002 - $0.0002
52-week range:
$0.0000 - $0.0842
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
0.19x
Volume:
6K
Avg. volume:
39.4K
1-year change:
-99.64%
Market cap:
$6K
Revenue:
$20.2M
EPS (TTM):
-$0.33
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $8.5M $17.3M $3M $7.2M $20.2M
Revenue Growth (YoY) 198.45% 103.96% -82.44% 136.36% 181.37%
 
Cost of Revenues $15.9M $32.9M $4.9M $10.3M $19.1M
Gross Profit -$7.4M -$15.7M -$1.9M -$3.1M $1M
Gross Profit Margin -87.73% -90.73% -63.02% -43.79% 5.03%
 
R&D Expenses $33.5M $36.7M $3.1M $3.5M --
Selling, General & Admin $50.4M $63.5M $20.3M $14.1M $10.4M
Other Inc / (Exp) -$5.7M $3.7M $58.5M $11.9M $9.9M
Operating Expenses $83.8M $100.2M $21.1M $11.2M $7M
Operating Income -$91.2M -$115.9M -$23M -$14.4M -$6M
 
Net Interest Expenses $5.5M $5.7M $5.1M $5.7M $5.8M
EBT. Incl. Unusual Items -$102M -$117.7M $28.8M -$11.9M -$4.5M
Earnings of Discontinued Ops. -- -- -$68.4M -$69.7M -$5M
Income Tax Expense $23K -- $15K $63K --
Net Income to Company -$102M -$117.7M -$39.6M -$81.7M -$9.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$102M -$117.7M $28.8M -$11.9M -$4.5M
 
Basic EPS (Cont. Ops) -$8.94 -$4.11 -$1.39 -$2.81 -$0.32
Diluted EPS (Cont. Ops) -$8.94 -$4.11 -$1.39 -$2.81 -$0.32
Weighted Average Basic Share $11.4M $28.7M $28.5M $29.1M $29.8M
Weighted Average Diluted Share $11.4M $28.7M $28.5M $29.1M $29.8M
 
EBITDA -$87.3M -$109M -$21.8M -$13.5M -$5M
EBIT -$91.2M -$115.9M -$23M -$14.4M -$6M
 
Revenue (Reported) $8.5M $17.3M $3M $7.2M $20.2M
Operating Income (Reported) -$91.2M -$115.9M -$23M -$14.4M -$6M
Operating Income (Adjusted) -$91.2M -$115.9M -$23M -$14.4M -$6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $2.6M $4.4M $5M $2.3M $7.1M
Revenue Growth (YoY) 250.68% 69.46% 13.76% -- 246.12%
 
Cost of Revenues $4.9M $9.9M $8.3M $2.5M $6.1M
Gross Profit -$2.3M -$5.6M -$3.4M -$118K $1M
Gross Profit Margin -90.02% -127.85% -67.7% -5.03% 14.1%
 
R&D Expenses $9M $8.8M $6.3M $730K --
Selling, General & Admin $15.2M $15.9M $9.4M $4.6M $2.6M
Other Inc / (Exp) -$1.6M $382K $37.4M $4.6M $1.5M
Operating Expenses $24.1M $24.7M $15.7M $5.3M $2M
Operating Income -$26.4M -$30.3M -$19.1M -$5.4M -$1M
 
Net Interest Expenses $1.4M $1.4M $1.3M $1.2M $1.4M
EBT. Incl. Unusual Items -$29.4M -$31.3M $15.2M -$2M -$1.3M
Earnings of Discontinued Ops. -- -- -- -$31.7M -$95K
Income Tax Expense $23K -- $82K -- --
Net Income to Company -$29.4M -$31.3M $15.1M -- -$1.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$29.4M -$31.3M $15.1M -$33.8M -$1.3M
 
Basic EPS (Cont. Ops) -$1.05 -$1.12 $0.53 -$1.16 -$0.05
Diluted EPS (Cont. Ops) -$1.05 -$1.12 $0.41 -$1.16 -$0.05
Weighted Average Basic Share $27.9M $28M $28.5M $29.3M $29.9M
Weighted Average Diluted Share $27.9M $28M $37.2M $29.3M $29.9M
 
EBITDA -$25.1M -$28.6M -$17.4M -$435K -$763K
EBIT -$26.4M -$30.3M -$19.1M -$435K -$1M
 
Revenue (Reported) $2.6M $4.4M $5M $2.3M $7.1M
Operating Income (Reported) -$26.4M -$30.3M -$19.1M -$5.4M -$1M
Operating Income (Adjusted) -$26.4M -$30.3M -$19.1M -$435K -$1M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $8.5M $17.3M $16.4M $7.2M $20.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $15.9M $32.9M $31.9M $10.3M $19.1M
Gross Profit -$7.4M -$15.7M -$15.5M -$3.1M $1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $33.5M $36.7M $28.2M $3.5M --
Selling, General & Admin $50.4M $63.5M $47.7M $14.7M $10.4M
Other Inc / (Exp) -$5.7M $3.7M $58.5M $11.9M $9.9M
Operating Expenses $83.8M $100.2M $75.8M $18.2M $7.1M
Operating Income -$91.2M -$115.9M -$91.4M -$21.2M -$6.1M
 
Net Interest Expenses $5.5M $5.7M $5.1M $3.1M $5.8M
EBT. Incl. Unusual Items -$102M -$117.7M -$39.5M -$12.4M -$4.5M
Earnings of Discontinued Ops. -- -- -- -$69.2M -$5M
Income Tax Expense $23K -- $82K -- --
Net Income to Company -$102M -$117.7M -$39.6M -- -$9.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$102M -$117.7M -$40.8M -$81.7M -$4.5M
 
Basic EPS (Cont. Ops) -$3.67 -$4.12 -$1.45 -$2.81 -$0.32
Diluted EPS (Cont. Ops) -$3.67 -$4.12 -$1.58 -$2.81 -$0.32
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$87.3M -$108.9M -$84.2M -$5.9M -$5.1M
EBIT -$91.2M -$115.9M -$91.4M -$6.8M -$6.1M
 
Revenue (Reported) $8.5M $17.3M $16.4M $7.2M $20.1M
Operating Income (Reported) -$91.2M -$115.9M -$91.4M -$21.2M -$6.1M
Operating Income (Adjusted) -$91.2M -$115.9M -$91.4M -$6.8M -$6.1M
Period Ending 2022-01-01 2023-01-01 2024-01-01 2025-01-01
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $131.2M $100.9M $76.2M $29.4M $14M
Short Term Investments $105.8M $76.7M $44.9M $3.2M --
Accounts Receivable, Net $2.2M $3.6M $17.9M $11.4M $7.9M
Inventory $13M $16.4M $1.8M $4.3M $1.8M
Prepaid Expenses $5M -- -- -- --
Other Current Assets -- $5.3M $1.3M $678K $641K
Total Current Assets $151.4M $126.3M $117.9M $46.3M $25.6M
 
Property Plant And Equipment $14M $18.2M $5.5M $4M $3M
Long-Term Investments $9.1M $7.8M -- -- --
Goodwill $12M $12M -- -- --
Other Intangibles $5.7M $5M -- -- --
Other Long-Term Assets $717K $1.2M $10M $3.7M $94K
Total Assets $192.5M $169.8M $133.4M $54M $28.6M
 
Accounts Payable $8.3M $7.5M $2.5M $2.8M $1.3M
Accrued Expenses $588K $1.5M $696K $662K $2M
Current Portion Of Long-Term Debt -- -- -- $1.9M $7M
Current Portion Of Capital Lease Obligations $933K $395K $319K $718K $957K
Other Current Liabilities $5.4M $1.5M $13.8M $10.7M $194K
Total Current Liabilities $21.9M $18.5M $19.9M $18.9M $12.4M
 
Long-Term Debt $40.1M $45M $38.5M $35.9M $27.8M
Capital Leases -- -- -- -- --
Total Liabilities $66M $64.1M $58.4M $54.8M $40.2M
 
Common Stock $28K $28K $29K $29K $30K
Other Common Equity Adj $280K -$217K -$869K -$866K -$768K
Common Equity $126.6M $105.7M $75M -$879.1K -$11.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $126.6M $105.7M $75M -$879K -$11.6M
 
Total Liabilities and Equity $192.5M $169.8M $133.4M $54M $28.6M
Cash and Short Terms $131.2M $100.9M $76.2M $29.4M $14M
Total Debt $40.1M $45M $38.5M $37.8M $34.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $131.2M $100.9M $76.2M -- $14M
Short Term Investments $105.8M $76.7M $44.9M $3.2M --
Accounts Receivable, Net $2.2M $3.6M $21.1M -- $7.9M
Inventory $13M $16.4M $13.3M -- $1.8M
Prepaid Expenses $5M -- -- -- --
Other Current Assets -- $5.3M $1.3M $678K $641K
Total Current Assets $151.4M $126.3M $117.9M -- $25.6M
 
Property Plant And Equipment $14M $18.2M $13.1M -- $3M
Long-Term Investments $9.1M $7.8M $500K -- --
Goodwill $12M $12M -- -- --
Other Intangibles $5.7M $5M -- -- --
Other Long-Term Assets $717K $1.2M $10M $3.7M $94K
Total Assets $192.5M $169.8M $133.4M -- $28.6M
 
Accounts Payable $8.3M $7.5M $4.7M -- $1.3M
Accrued Expenses $588K $1.5M $696K $662K $2M
Current Portion Of Long-Term Debt -- -- -- $1.9M $7M
Current Portion Of Capital Lease Obligations $933K $395K $319K $718K $957K
Other Current Liabilities $5.4M $1.5M $13.8M $10.7M $194K
Total Current Liabilities $21.9M $18.5M $19.9M -- $12.4M
 
Long-Term Debt $40.1M $45M $38.5M -- $27.8M
Capital Leases -- -- -- -- --
Total Liabilities $66M $64.1M $58.4M -- $40.2M
 
Common Stock $28K $28K $29K -- $30K
Other Common Equity Adj $280K -$217K -$869K -$866K -$768K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $126.6M $105.7M $75M -- -$11.6M
 
Total Liabilities and Equity $192.5M $169.8M $133.4M -- $28.6M
Cash and Short Terms $131.2M $100.9M $76.2M -- $14M
Total Debt $40.1M $45M $38.5M $34.5M $34.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$102M -$117.7M -$39.6M -$81.7M -$9.5M
Depreciation & Amoritzation $3.9M $6.9M $1.2M $874K $1M
Stock-Based Compensation $12.1M $13.8M $3.4M $3M $459K
Change in Accounts Receivable -$1.9M -$1.5M -$5.2M -$1.1M -$4M
Change in Inventories -$3.9M -$3.9M -$65K -$2.5M $2.5M
Cash From Operations -$85.2M -$99.7M -$88.9M -$63.6M -$31.7M
 
Capital Expenditures $11.2M $10M $228K $219K $112K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$63.8M $19.1M $104.8M $58.6M $22.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $34.8M -- --
Long-Term Debt Repaid -- -- -$44.6M -- -$2.6M
Repurchase of Common Stock -- -- $111K -- --
Other Financing Activities -$2.5M -$4.2M -$2.1M -$2.4M -$225K
Cash From Financing $164.4M $79.6M -$11.6M -$2.2M -$2.9M
 
Beginning Cash (CF) $25.4M $24.2M $31.3M $26.2M $14M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $15.8M -$1.2M $7.1M -$5.1M -$12.2M
Ending Cash (CF) $41.5M $22.9M $41.4M $23.1M $2.1M
 
Levered Free Cash Flow -$96.4M -$109.7M -$89.1M -$63.8M -$31.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$29.4M -$31.3M $15.1M -- -$1.4M
Depreciation & Amoritzation $1.3M $1.7M $1.6M -- $250K
Stock-Based Compensation $2.8M $3.5M $1.9M -- --
Change in Accounts Receivable -$267K $557K -$872K -- -$549K
Change in Inventories -$2M -$1.9M $1.3M -- $2.4M
Cash From Operations -$24.1M -$22.6M -$13M -- -$4.1M
 
Capital Expenditures $3.4M $3.4M $1.5M -$968K -$36K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$9.6M -$11.4M $12.2M -- $5.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- $49K -- --
Other Financing Activities $136K -$515K $501K -$490K --
Cash From Financing $433K -$514K -$15K -- -$225K
 
Beginning Cash (CF) $25.4M $24.2M $31.3M -- $14M
Foreign Exchange Rate Adjustment $199K $98K -$28K -- $234K
Additions / Reductions -$33.1M -$34.4M -$805K -- $1.4M
Ending Cash (CF) -$7.5M -$10.1M $30.5M -- $15.7M
 
Levered Free Cash Flow -$27.5M -$26M -$14.5M -$17M -$4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$102M -$117.7M -$39.6M -- -$9.5M
Depreciation & Amoritzation $3.9M $6.9M $7.1M -- $1M
Stock-Based Compensation $12.1M $13.8M $9.4M -- $459K
Change in Accounts Receivable -$1.9M -$1.5M -$452K -- -$4M
Change in Inventories -$3.9M -$3.9M $3.1M -- $2.5M
Cash From Operations -$85.2M -$99.7M -$85M -- -$31.7M
 
Capital Expenditures $11.2M $10M $4M $219K $112K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$63.8M $19.1M $104.8M -- $22.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- $111K -- --
Other Financing Activities -$2.5M -$4.2M -$2.1M -- --
Cash From Financing $164.4M $79.6M -$12.1M -- -$2.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $15.8M -$1.2M $7.1M -- -$12.2M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$96.4M -$109.7M -$89M -$63.3M -$31.8M
Period Ending 2022-01-01 2023-01-01 2024-01-01 2025-01-01
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 1

Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.

Buy
75
AXSM alert for Jan 1

Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.

Sell
50
NUTX alert for Jan 1

Nutex Health, Inc. [NUTX] is down 9.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock